PAPER Mahnashi MH, Ayaz M, Ghufran M, Almazni IA, Alqahtani O, Alyami BA, Alqahtani YS, Khan HA, Sadiq A, Waqas M
SEARCH RESULTS
331159 RESULTS
PAPER Castillo Ordoñez WO, Aristizabal-Pachon AF, Alves LB, Giuliatti S
Epigenetic regulation exerted by Caliphruria subedentata and galantamine: an in vitro and in silico approach for mimic Alzheimer's disease.
J Biomol Struct Dyn. 2023 Oct 10;:1-16. PubMed: 37814967PAPER Keefe AJ, Gabrych DR, Zhu Y, Vocadlo DJ, Silverman MA
Axonal Transport of Lysosomes Is Unaffected in Glucocerebrosidase-Inhibited iPSC-Derived Forebrain Neurons.
eNeuro. 2023 Oct;10(10) Print 2023 Oct PubMed: 37816595PAPER Vasquez R, Batista L, Cuya T
Computational Study on the Enzyme-Ligand Relationship between Cannabis Phytochemicals and Human Acetylcholinesterase: Implications in Alzheimer's Disease.
J Phys Chem B. 2023 Oct 19;127(41):8780-8795. Epub 2023 Oct 10 PubMed: 37815196PAPER Zheng JY, Kang T, Jiang C, Lin LK, Gao L, Jin LH, Shu Y, Zhang JJ, Li C, Chen B, Shen YH
Gut microbiome and brain transcriptome analyses reveal the effect of walnut oil in preventing scopolamine-induced cognitive impairment.
Food Funct. 2023 Oct 30;14(21):9707-9724. PubMed: 37814808PAPER Vu TA, Fenwick E, Doshi K, Gupta P, Quek SY, Chen C, Ting S, Ng AS, Yap P, Yeo D, Milea D, Lamoureux EL
Content development of the VISION-Cog: a novel tool to assess cognitive impairment in visually impaired older adults in Singapore.
BMJ Open. 2023 Oct 10;13(10):e070850. PubMed: 37816566PAPER Lew CO, Zhou L, Mazurowski MA, Doraiswamy PM, Petrella JR, Alzheimer's Disease Neuroimaging Initiative
MRI-based Deep Learning Assessment of Amyloid, Tau, and Neurodegeneration Biomarker Status across the Alzheimer Disease Spectrum.
Radiology. 2023 Oct;309(1):e222441. PubMed: 37815445PAPER Montenegro P, Chen P, Kang J, Lee SH, Leone S, Shen J
Human Presenilin-1 delivered by AAV9 rescues impaired γ-secretase activity, memory deficits, and neurodegeneration in Psen mutant mice.
Proc Natl Acad Sci U S A. 2023 Oct 17;120(42):e2306714120. Epub 2023 Oct 10 PubMed: 37816062PAPER Beauchamp LC, Dore V, Villemagne VL, Xu S, Finkelstein D, Barnham KJ, Rowe C
Using 18F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal Degeneration in Parkinson Disease.
Neurology. 2023 Nov 27;101(22):e2314-e2324. PubMed: 37816639PAPER Xu S, Liu H, Wang C, Deng Y, Xu B, Yang T, Liu W
Dual roles of UPRer and UPRmt in neurodegenerative diseases.
J Mol Med (Berl). 2023 Dec;101(12):1499-1512. Epub 2023 Oct 10 PubMed: 37817014PAPER Pritzkow S, Ramirez F, Lyon A, Schulz PE, Appleby B, Moda F, Ramirez S, Notari S, Gambetti P, Soto C
Detection of prions in the urine of patients affected by sporadic Creutzfeldt-Jakob disease.
Ann Clin Transl Neurol. 2023 Dec;10(12):2316-2323. Epub 2023 Oct 10 PubMed: 37814583PAPER Shammas MK, Nie Y, Gilsrud A, Huang X, Narendra DP, Chinnery PF
CHCHD10 mutations induce tissue-specific mitochondrial DNA deletions with a distinct signature.
Hum Mol Genet. 2023 Dec 12;33(1):91-101. PubMed: 37815936PAPER Gaikwad S, Senapati S, Haque MA, Kayed R
Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies.
Alzheimers Dement. 2024 Jan;20(1):709-727. Epub 2023 Oct 9 PubMed: 37814508PAPER Northall A, Doehler J, Weber M, Tellez I, Petri S, Prudlo J, Vielhaber S, Schreiber S, Kuehn E
Multimodal layer modelling reveals in vivo pathology in amyotrophic lateral sclerosis.
Brain. 2024 Mar 1;147(3):1087-1099. PubMed: 37815224PAPER Rao SS, Lago L, Volitakis I, Shukla JJ, McColl G, Finkelstein DI, Adlard PA
Retraction Note: Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology.
Neurotherapeutics. 2023 Oct;20(6):1894. PubMed: 37817049Current Filters
No filters selected